Cargando…

Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease

Polycystic kidney disease (PKD) is the most common inherited cause of kidney failure and currently has limited treatment options. Increasing water intake reduces renal cyst growth in the pck rat (a genetic ortholog of autosomal recessive PKD) but it is not clear if this beneficial effect is present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagar, Priyanka S., Zhang, Jennifer, Luciuk, Magda, Mannix, Carly, Wong, Annette T. Y., Rangan, Gopala K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314616/ https://www.ncbi.nlm.nih.gov/pubmed/30601830 http://dx.doi.org/10.1371/journal.pone.0209186

Ejemplares similares

Relative Validity of a Beverage Frequency Questionnaire Used to Assess Fluid Intake in the Autosomal Dominant Polycystic Kidney Disease Population
por: Mannix, Carly, et al.
Publicado: (2018)

Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?
por: Tasneem, Moomal, et al.
Publicado: (2018)

Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease
por: Sagar, Priyanka S., et al.
Publicado: (2021)

Regression of Peritubular Capillaries Coincides with Angiogenesis and Renal Cyst Growth in Experimental Polycystic Kidney Disease
por: O’Brien, Kristal, et al.
Publicado: (2020)

Cardiovascular Manifestations and Management in ADPKD
por: Sagar, Priyanka S., et al.
Publicado: (2023)

Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease
por: Zhang, Jennifer Q. J., et al.
Publicado: (2021)

Long-term dietary nitrate supplementation does not reduce renal cyst growth in experimental autosomal dominant polycystic kidney disease
por: Zhang, Jennifer Q. J., et al.
Publicado: (2021)

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
por: Wong, Annette T Y, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease (ADPKD) is associated with coronary arterial dilatation in end-stage renal failure patients
por: Chiha, Joseph, et al.
Publicado: (2012)

Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease
por: Ta, Michelle H. T., et al.
Publicado: (2014)

Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease
por: Chandra, Ashley N., et al.
Publicado: (2021)

Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney Disease
por: Saravanabavan, Sayanthooran, et al.
Publicado: (2022)

Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963–2014)
por: Fernando, Mangalee R., et al.
Publicado: (2017)

Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease
por: Wong, Annette T. Y., et al.
Publicado: (2020)

Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells
por: Ta, Michelle H. T., et al.
Publicado: (2015)

Efficacy of beetroot juice on reducing blood pressure in hypertensive adults with autosomal dominant polycystic kidney disease (BEET-PKD): study protocol for a double-blind, randomised, placebo-controlled trial
por: Sagar, Priyanka S., et al.
Publicado: (2023)

Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease
por: Ta, Michelle H. T., et al.
Publicado: (2016)

Clinical characteristics and outcomes of hyponatraemia associated with oral water intake in adults: a systematic review
por: Rangan, Gopala K, et al.
Publicado: (2021)

Role of extracellular ATP and P2 receptor signaling in regulating renal cyst growth and interstitial inflammation in polycystic kidney disease
por: Rangan, Gopi
Publicado: (2013)

Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
por: Higashihara, Eiji, et al.
Publicado: (2014)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
por: Ryu, Hyunjin, et al.
Publicado: (2020)

Standardised Outcomes in Nephrology—Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease
por: Cho, Yeoungjee, et al.
Publicado: (2017)

Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey
por: El-Damanawi, Ragada, et al.
Publicado: (2017)

Caffeine intake by patients with autosomal dominant polycystic kidney disease
por: Vendramini, L.C., et al.
Publicado: (2012)

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016)

Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease
por: Amin, Sneha, et al.
Publicado: (2023)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial
por: El-Damanawi, R, et al.
Publicado: (2020)

High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial
por: El-Damanawi, R, et al.
Publicado: (2020)

Hypertension in Polycystic Renal Disease
por: Goddard, D.H., et al.
Publicado: (1980)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Experimental Models of Polycystic Kidney Disease: Applications and Therapeutic Testing
por: Sieben, Cynthia J., et al.
Publicado: (2023)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

Experimental Models of Renal Disease and the Cardiovascular System
por: Grossman, Rebecca C.
Publicado: (2010)

Polycystic kidney disease complicates renal pathology in a family with Fabry disease
por: Johar, Leepakshi, et al.
Publicado: (2022)

Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review
por: Natale, Patrizia, et al.
Publicado: (2021)

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease
por: Lai, Silvia, et al.
Publicado: (2016)

Young-Adult Polycystic Kidney Disease is Associated with Major Cardiovascular Complications
por: Chuang, Ya-Wen, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease complicating renal ectopia and managed with renal transplantation
por: Connor, Andrew, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3iookapo9b9qdpmbvk0nuvgcpa